6.
Bolton K, Ptashkin R, Gao T, Braunstein L, Devlin S, Kelly D
. Cancer therapy shapes the fitness landscape of clonal hematopoiesis. Nat Genet. 2020; 52(11):1219-1226.
PMC: 7891089.
DOI: 10.1038/s41588-020-00710-0.
View
7.
Raudvere U, Kolberg L, Kuzmin I, Arak T, Adler P, Peterson H
. g:Profiler: a web server for functional enrichment analysis and conversions of gene lists (2019 update). Nucleic Acids Res. 2019; 47(W1):W191-W198.
PMC: 6602461.
DOI: 10.1093/nar/gkz369.
View
8.
Pich O, Reyes-Salazar I, Gonzalez-Perez A, Lopez-Bigas N
. Discovering the drivers of clonal hematopoiesis. Nat Commun. 2022; 13(1):4267.
PMC: 9308779.
DOI: 10.1038/s41467-022-31878-0.
View
9.
Bronkhorst A, Ungerer V, Holdenrieder S
. The emerging role of cell-free DNA as a molecular marker for cancer management. Biomol Detect Quantif. 2019; 17:100087.
PMC: 6425120.
DOI: 10.1016/j.bdq.2019.100087.
View
10.
Danecek P, Auton A, Abecasis G, Albers C, Banks E, DePristo M
. The variant call format and VCFtools. Bioinformatics. 2011; 27(15):2156-8.
PMC: 3137218.
DOI: 10.1093/bioinformatics/btr330.
View
11.
Chen J, Huang J, Luo B, Dong S, Wang R, Jiang Z
. PIK3CD induces cell growth and invasion by activating AKT/GSK-3β/β-catenin signaling in colorectal cancer. Cancer Sci. 2019; 110(3):997-1011.
PMC: 6398891.
DOI: 10.1111/cas.13931.
View
12.
Henrich K, Bauer T, Schulte J, Ehemann V, Deubzer H, Gogolin S
. CAMTA1, a 1p36 tumor suppressor candidate, inhibits growth and activates differentiation programs in neuroblastoma cells. Cancer Res. 2011; 71(8):3142-51.
DOI: 10.1158/0008-5472.CAN-10-3014.
View
13.
Feusier J, Arunachalam S, Tashi T, Baker M, VanSant-Webb C, Ferdig A
. Large-Scale Identification of Clonal Hematopoiesis and Mutations Recurrent in Blood Cancers. Blood Cancer Discov. 2021; 2(3):226-237.
PMC: 8133376.
DOI: 10.1158/2643-3230.BCD-20-0094.
View
14.
Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N
. The Sequence Alignment/Map format and SAMtools. Bioinformatics. 2009; 25(16):2078-9.
PMC: 2723002.
DOI: 10.1093/bioinformatics/btp352.
View
15.
Jaiswal S, Fontanillas P, Flannick J, Manning A, Grauman P, Mar B
. Age-related clonal hematopoiesis associated with adverse outcomes. N Engl J Med. 2014; 371(26):2488-98.
PMC: 4306669.
DOI: 10.1056/NEJMoa1408617.
View
16.
Bick A, Weinstock J, Nandakumar S, Fulco C, Bao E, Zekavat S
. Inherited causes of clonal haematopoiesis in 97,691 whole genomes. Nature. 2020; 586(7831):763-768.
PMC: 7944936.
DOI: 10.1038/s41586-020-2819-2.
View
17.
Moes-Sosnowska J, Rzepecka I, Chodzynska J, Dansonka-Mieszkowska A, Szafron L, Balabas A
. Clinical importance of FANCD2, BRIP1, BRCA1, BRCA2 and FANCF expression in ovarian carcinomas. Cancer Biol Ther. 2019; 20(6):843-854.
PMC: 6606037.
DOI: 10.1080/15384047.2019.1579955.
View
18.
Legare S, Cavallone L, Mamo A, Chabot C, Sirois I, Magliocco A
. The Estrogen Receptor Cofactor SPEN Functions as a Tumor Suppressor and Candidate Biomarker of Drug Responsiveness in Hormone-Dependent Breast Cancers. Cancer Res. 2015; 75(20):4351-63.
DOI: 10.1158/0008-5472.CAN-14-3475.
View
19.
Leal A, van Grieken N, Palsgrove D, Phallen J, Medina J, Hruban C
. White blood cell and cell-free DNA analyses for detection of residual disease in gastric cancer. Nat Commun. 2020; 11(1):525.
PMC: 6985115.
DOI: 10.1038/s41467-020-14310-3.
View
20.
McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A
. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome Res. 2010; 20(9):1297-303.
PMC: 2928508.
DOI: 10.1101/gr.107524.110.
View